HOLX
May 1, 2023 - AI Summary
Undervalued by 133.8% based on the discounted cash flow analysis.
Market cap | $12.65 Billion |
---|---|
Enterprise Value | $11.49 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $3.35 |
Beta | 0.55 |
Outstanding Shares | 225,774,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.02 |
---|---|
PEG | -20.88 |
Price to Sales | 3.36 |
Price to Book Ratio | 2.86 |
Enterprise Value to Revenue | 2.85 |
Enterprise Value to EBIT | 19.33 |
Enterprise Value to Net Income | 20 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.06 |
No data
No data
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.